Lv51
1098 积分 2024-06-18 加入
Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration
1小时前
已完结
Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma
10天前
已完结
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation–Mediated TXNRD1 Stabilization to Suppress Ferroptosis
18天前
已完结
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
20天前
已完结
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
25天前
已完结
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1
1个月前
已完结
EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers
1个月前
已完结
Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance
1个月前
已完结
Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration
2个月前
已完结
Kupffer cell calibration of T cell responses via VSIG4-CD5 interaction promotes tumor evasion
2个月前
已完结
皖公网安备34019202002308
